Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other financing activities (2023 - 2025)

Neurogene (NGNE) has disclosed Other financing activities for 2 consecutive years, with $166000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities rose 103.87% year-over-year to $166000.0, compared with a TTM value of $4.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $4.3 million, changed N/A over the prior year.
  • Other financing activities was $166000.0 for Q3 2025 at Neurogene, down from $4.3 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.3 million in Q1 2024 and bottomed at -$4.3 million in Q3 2024.